Khoylou Marta Ph.D.

Academic title: MSc.

Phone: +420 585632145, +420 585632366

Groups: IMTM, LEM, STAFF

My main focus is use immunohistochemical methods and caplture laser microdissection in establishment of new diagnostic and prognostic markers in human and animal research.

I also work as an occupational safety manager at the Institute of Molecular and Translational Medicine. I am responsible for the proper management of safety inspections of employees, training of employees in occupational safety and organization of the operating rules of the institute.

BRAUER, R., J. TURECKOVA, I. KANCHEV, M. KHOYLOU, J. ŠKARDA, J. PROCHAZKA, F. SPOUTIL, I. BECK, O. ŽBODÁKOVÁ, P. KASPAREK, V. KORINEK, K. CHALUPSKÝ, T. KARHU, K. HERZIG, M. HAJDÚCH, M. GREGOR, R. SEDLÁČEK

MMP-19 deficiency causes aggravation of colitis due to defects in innate immune cell function. Mucosal Immunology. 2016, 9(4), 974-985, ISSN: 1933-0219, PMID: 26555704, PDF.

SURINOVA, S., M. CHOI, S. TAO, P. SCHÜFFLER, C. CHANG, T. CLOUGH, K. VYSLOUŽIL, M. KHOYLOU, J. SROVNAL, Y. LIU, M. MATONDO, R. HÜTTENHAIN, H. WEISSER, J. BUHMANN, M. HAJDÚCH, H. BRENNER, O. VITEK, R. AEBERSOLD

Prediction of colorectal cancer diagnosis based on circulating plasma proteins. EMBO Molecular Medicine. 2015, 7(9), 1166-1178, ISSN: 1757-4676, PMID: 26253081,

GRELL, P., P. FABIAN, M. KHOYLOU, L. RADOVÁ, O. SLABÝ, R. HRSTKA, R. VYZULA, M. HAJDÚCH, M. SVOBODA

Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab. International Journal of Oncology. 2012, 41(4), 1204-1212, ISSN: 1019-6439, PMID: 22842582,

Khoylou Marta Ph.D.

About me

Journals